European Renal Association   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: United Kingdom (1963)

Organization Overview

First Clinical Trial
2014
NCT01955187
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

ERA-EDTA | ERA-EDTA (Europ. Renal Association-Europ. Dialysis and Transplant Association)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glomerulonephritis, Membranous (Phase 3)

Kidney Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5